The benefits of long chain polyunsaturated omega-3 fatty acids (n-3 PUFA) from fish or administered as supplements remain controversial regarding prostate cancer (PCa). Based on the currently available evidence no clear benefit of n-3 PUFA intake to generally reduce PCa incidence has been found. On the other hand n-3 PUFAs have a clear influence on the development of already existing PCa. The intake of n-3-PUFAs considerably reduces the risk of metastasis and PCa-related mortality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00120-014-3612-3 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!